CS196267B2 - Method of producing water-soluble compounds having low-molecular weight,containing diamino pimelic acid - Google Patents

Method of producing water-soluble compounds having low-molecular weight,containing diamino pimelic acid Download PDF

Info

Publication number
CS196267B2
CS196267B2 CS753097A CS309775A CS196267B2 CS 196267 B2 CS196267 B2 CS 196267B2 CS 753097 A CS753097 A CS 753097A CS 309775 A CS309775 A CS 309775A CS 196267 B2 CS196267 B2 CS 196267B2
Authority
CS
Czechoslovakia
Prior art keywords
water
soluble
carried out
process according
molecular weight
Prior art date
Application number
CS753097A
Other languages
Czech (cs)
English (en)
Inventor
Pierre Jolles
D Migliore-Samour
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of CS196267B2 publication Critical patent/CS196267B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15—Corynebacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CS753097A 1974-05-06 1975-05-05 Method of producing water-soluble compounds having low-molecular weight,containing diamino pimelic acid CS196267B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7415570A FR2269961B1 (fr) 1974-05-06 1974-05-06

Publications (1)

Publication Number Publication Date
CS196267B2 true CS196267B2 (en) 1980-03-31

Family

ID=9138474

Family Applications (1)

Application Number Title Priority Date Filing Date
CS753097A CS196267B2 (en) 1974-05-06 1975-05-05 Method of producing water-soluble compounds having low-molecular weight,containing diamino pimelic acid

Country Status (14)

Country Link
US (1) US4013788A (fr)
JP (1) JPS50155685A (fr)
BE (1) BE828635A (fr)
CA (1) CA1037028A (fr)
CH (1) CH604725A5 (fr)
CS (1) CS196267B2 (fr)
DE (1) DE2519938A1 (fr)
DK (1) DK194975A (fr)
FR (1) FR2269961B1 (fr)
GB (1) GB1502320A (fr)
IL (1) IL47205A (fr)
NL (1) NL7505246A (fr)
SE (1) SE7505032L (fr)
SU (1) SU727112A3 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
FR2321896A1 (fr) * 1975-08-29 1977-03-25 Anvar Agents adjuvants immunologiques actifs en solution aqueuse
US4148877A (en) * 1975-12-29 1979-04-10 Choay S. A. Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
FR2378855A1 (fr) * 1977-01-27 1978-08-25 Cassenne Lab Sa Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
GB1598457A (en) * 1977-03-22 1981-09-23 Glaxo Lab Ltd Process for the preparation of a fraction containing peptidoglycan material from streptomyces griseus
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
DE3011461C2 (de) * 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
FR2480604A1 (fr) * 1980-04-22 1981-10-23 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
JPS57163835U (fr) * 1981-04-07 1982-10-15
JPH0742310B2 (ja) * 1984-01-23 1995-05-10 味の素株式会社 Ｌ−アスパルチル−ｌ−フエニルアラニン又はその低級アルキルエステルの晶析法
IT1237903B (it) * 1989-12-14 1993-06-18 Medidom Lab Derivati semisintetici ad attivita' immunomodulante atti alla somminitrazione parenterale ed orale
EP0681479B1 (fr) * 1993-01-29 1999-04-28 Vetrepharm, Inc. Composition immunotherapeutique
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
JP4759182B2 (ja) * 2001-08-03 2011-08-31 花王株式会社 水溶性ショウキョウエキス

Also Published As

Publication number Publication date
CA1037028A (fr) 1978-08-22
FR2269961B1 (fr) 1978-03-24
SE7505032L (sv) 1975-11-07
IL47205A0 (en) 1975-06-25
US4013788A (en) 1977-03-22
DK194975A (da) 1975-11-07
NL7505246A (nl) 1975-11-10
DE2519938A1 (de) 1975-11-27
SU727112A3 (ru) 1980-04-05
CH604725A5 (fr) 1978-09-15
FR2269961A1 (fr) 1975-12-05
BE828635A (fr) 1975-10-30
IL47205A (en) 1978-06-15
JPS50155685A (fr) 1975-12-16
GB1502320A (en) 1978-03-01

Similar Documents

Publication Publication Date Title
CS196267B2 (en) Method of producing water-soluble compounds having low-molecular weight,containing diamino pimelic acid
US6352697B1 (en) Saponin preparations and use thereof in iscoms
EP0549617B1 (fr) Vaccin ameliore
US5965144A (en) Chitosan induced immunopotentiation
Rietschel et al. Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin
EP0325191B1 (fr) Composition et procédé pour protéger contre des maladies causées par des micro-organismes
MX2007007090A (es) Vacunas glicoconjugadas que contienen peptidoglicanos.
JP2002534480A (ja) 改良サポニンアジュバント組成物およびそれに関する方法
JP2761809B2 (ja) クイラヤ サポニンアジュバントおよびこれを含むワクチン製剤
US4079126A (en) Method of preparing a component consisting of sugar, lipid and protein derived from Pseudomonas aeruginosa which possess anti-tumor and interferon inducing properties
US4702910A (en) Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pretecting Pseudomonas aeruginosa infection
JPH06340543A (ja) 持続性遊離組成物中の薬理学的活性成分の安定
US4490362A (en) Immunopotentiator comprising the B chain of ricin as an active ingredient
IL165970A (en) Method of isolating biologically active fraction containing clinically acceptable native s-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides
Migliore-Samour et al. Hydrosoluble immunopotentiating substances extracted from Corynebacterium parvum
EP1108738B1 (fr) Support immunostimulant pour des vaccins
EP0028815A2 (fr) Utilisation de la ricine et d'une composition pharmaceutique la contenant pour augmenter la réponse immunologique
EP0238739B1 (fr) Vaccin de polysaccharide capsulaire de Klebsiella
US6190670B1 (en) Use of mCRP to enhance immune responses
US5114712A (en) Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection
EP0646377A1 (fr) Extraits de tumeurs exemptes de cellules conjuguées à l'albumine, compositions antigéniques les comprenant, anticorps correspondants, et applications
EP0420743A1 (fr) Vaccin protecteur contre l'hémophilose porcine
JPS6236500B2 (fr)
JPS59205326A (ja) アブリンａ含有免疫増強剤
CN115475240A (zh) 新疆栽培一枝蒿粗多糖作为口蹄疫灭活疫苗佐剂的应用